Research Progress on the Combination of Quorum-Sensing Inhibitors and Antibiotics against Bacterial Resistance

Jiahao Wang1, Xingyue Lu1, Chenjie Wang1

  • 1Key Laboratory for Green Pharmaceutical Technologies and Related Equipment of Ministry of Education & Key Laboratory Pharmaceutical Engineering of Zhejiang Province & College of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China.

PubMed

Insights

Quorum-sensing inhibitors (QSIs) combined with antibiotics show synergistic antibacterial effects, enhancing treatment efficacy and combating antibiotic resistance. This combination offers a promising strategy for bacterial infections.

Area of Science:

  • Microbiology
  • Bacterial pathogenesis
  • Drug discovery

Background:

  • Quorum-sensing (QS) regulates bacterial virulence and biofilm formation, impacting antibiotic resistance.
  • Quorum-sensing inhibitors (QSIs) can disrupt these processes but have limited standalone efficacy.
  • QS plays a critical role in bacterial communication and virulence.

Purpose of the Study:

  • To review the effects of combining QSIs with antibiotics against bacteria.
  • To elucidate the combined antibacterial mechanisms of QSIs and antibiotics.
  • To explore novel therapeutic strategies for bacterial infections.

Main Methods:

  • Literature review of studies on QSIs and antibiotic combinations.
  • Analysis of in vitro and in vivo research findings.
  • Examination of synergistic antibacterial mechanisms.

Main Results:

  • QSIs combined with antibiotics demonstrate enhanced therapeutic effects compared to QSIs alone.
  • Synergistic action ensures bactericidal efficiency and mitigates antibiotic resistance.
  • In vivo studies support the efficacy of this combined approach.

Conclusions:

  • Combining QSIs with antibiotics presents a potent strategy against bacterial infections.
  • This approach offers a way to overcome antibiotic resistance.
  • Future clinical applications for treating bacterial infections are promising.